How to Buy Lipella Pharmaceuticals Stock
Lipella Pharmaceuticals Inc
Lipella Pharmaceuticals Inc. , a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.
Lipella Pharmaceuticals stock last closed at $0.74, down 0.8% from the previous day, and has decreased 61.25% in one year. It has underperformed other stocks in the Biotechnology industry by 0.43 percentage points. Lipella Pharmaceuticals stock is currently +16.25% from its 52-week low of $0.64, and -72.55% from its 52-week high of $2.71.
As of May 3, 2024, there are 6.25M shares of LIPO outstanding. The market value of LIPO is $4.65M. In the past 24 hours, 15,050 LIPO shares were traded.
How to Buy Lipella Pharmaceuticals Stock
Wondering how to invest in Lipella Pharmaceuticals stock? Here's how.
- Decide where to buy Lipella Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you determine where to buy Lipella Pharmaceuticals stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Select your payment method and add your info.
- Research Lipella Pharmaceuticals stock: The Lipella Pharmaceuticals ticker symbol is LIPO. Is Lipella Pharmaceuticals stock a good investment? Should you buy shares of LIPO? How do LIPO's underlying business fundamentals look? Do top analysts think Lipella Pharmaceuticals is a good buy? Why has LIPO's stock price moved recently? (Hint: Our stock analysis website can help you understand if LIPO is a good stock to buy).
- Make your LIPO trade: Decide if you will purchase LIPO shares at the current market price or use a limit order to purchase LIPO stock at a specific price.
- Get key alerts regarding your investment in LIPO: Create a watchlist to key updates about your new investment in Lipella Pharmaceuticals stock.
Step 1: Decide where to buy Lipella Pharmaceuticals stock
You will need a brokerage account to access the NASDAQ market and buy LIPO shares.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Financial Services, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the best brokerage, you need to fill out some personal info so you can invest in LIPO today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create your new brokerage account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've created your account on the best stock broker app, your next step is to transfer the money for your investment:
Check out the video below for more details depositing money into your new brokerage account.
Step 4: Research Lipella Pharmaceuticals stock
After you have identified the best place to buy Lipella Pharmaceuticals stock, it's critical to analyze their stock before you invest, so you can wrap your head around the risk and opportunity.
Lipella Pharmaceuticals shares at a glance
LIPO Due Diligence Checks
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on LIPO's stock page.
Is LIPO stock undervalued or overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge LIPO's intrinsic value.
Using relative valuations methods:
- LIPO may be undervalued based on its P/B ratio of 1.48x, relative to Biotechnology industry P/B ratio of 6.01x
You can do additional valuation analysis on LIPO's stock here.
LIPO Financial Health Overview
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the LIPO balance sheet.
- LIPO has a low debt to equity ratio of 0.14.
- There are more short-term assets than long-term liabilities on the LIPO balance sheet.
- LIPO has cash burn of 3164606. It has sufficient cash and short-term investments to cover this for at least one year.
Negative Financial Indicators:
- LIPO has $3.29M in cash and short term investments. This is not enough to cover its annual cash burn of $3.16M.
- LIPO profit margin has gone up by 3.83 percentage points in the past year, but the company is still unprofitable.
Do analysts think it's a good time to buy LIPO stock
Out of 1 Wall Street analysts who research LIPO, the consensus analyst rating on LIPO is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Lipella Pharmaceuticals stock forecast page.
LIPO Trading Indicators
LIPO Performance Metrics
Last year, LIPO revenue was $449.62k. During the last three year, LIPO's revenue has increased by -81.05% per year. This was slower than the Biotechnology industry average of 29.63%.
Learn more about LIPO's earnings and revenue performance here.
Are LIPO insiders buying or selling the stock?
In the past year, executives and large shareholders at LIPO have bought more shares than they have sold.
Jonathan H. Kaufman, Director of LIPO, was the latest LIPO insider to buy. They bought $21,800.00 worth of LIPO stock on Mar 19, 2024.
Dig into more about who owns LIPO stock here.
Does LIPO stock generate passive income?
No, Lipella Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other investors have to say about LIPO?
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your LIPO trade
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount, use a limit order.
Hit the Open button and your broker will place your order.
If you need additional info about investing in stocks on eToro, click the how to video below:
Step 6: Get key alerts regarding your investment in LIPO
Now that you own some LIPO shares, you'll want to keep up with your stock purchase.
Start a watchlist to keep tabs on your LIPO stock.
LIPO Feed
How to Buy Stock in Lipella Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Lipella Pharmaceuticals stock right now:
- Decide where to buy Lipella Pharmaceuticals stock
- Create a brokerage account
- Put funds into your investment account
- Research Lipella Pharmaceuticals stock
- Make your LIPO trade
- Get key alerts regarding your investment in LIPO
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Lipella Pharmaceuticals, create a watchlist on WallStreetZen today.
More Articles You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.